A Single-Component CD40-Targeted Adenovirus Vector Displays Highly Efficient Transduction and Activation of Dendritic Cells in a Human Skin Substrate System
- 14 April 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 2 (3) , 218-223
Abstract
Dendritic cell (DC) based tumor vaccination usually involves the administration of ex vivo generated autologous DC. Transduction of DC by viral vectors in vivo has been proposed as a more standardized and easily clinically applicable approach. Previously, we have reported that an Ad5 vector targeted to CD40 via genetic capsid incorporation of CD40L achieves selective transduction of DC in vitro. In the present study, we evaluate the ability of this vector to deliver transgenes in a stringent human substrate system. We report the capacity of this CD40-targeted vector to infect, with high efficiency, cutaneous DC resident in human skin explants, while simultaneously inducing their activation and maturation. This latest generation of single-component, fully targeted vectors should make feasible the clinical testing of in vivo DC-targeted vaccines. Keywords: Adenovirus; dendritic cells; targeting; CD40 ligandKeywords
This publication has 15 references indexed in Scilit:
- Genetically Targeted Adenovirus Vector Directed to CD40-Expressing CellsJournal of Virology, 2003
- CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activationVaccine, 2003
- Prolonged Maturation and Enhanced Transduction of Dendritic Cells Migrated from Human Skin Explants After In Situ Delivery of CD40-Targeted Adenoviral VectorsThe Journal of Immunology, 2002
- Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cellsGene Therapy, 2002
- Genetic Targeting of an Adenovirus Vector via Replacement of the Fiber Protein with the Phage T4 FibritinJournal of Virology, 2001
- New Perspectives in Dendritic Cell-Based Cancer ImmunotherapyBioDrugs, 2001
- Dendritic Cells in Cancer ImmunotherapyCritical Reviews in Immunology, 2001
- Identification of a Conserved Receptor-Binding Site on the Fiber Proteins of CAR-Recognizing AdenoviridaeScience, 1999
- In Vivo Priming by DNA Injection Occurs Predominantly by Antigen TransferThe Journal of Immunology, 1999
- Methods for construction of adenovirus vectorsMolecular Biotechnology, 1995